Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT200605 in Acute Ischemic Stroke
NCT07205328Phase 2Recruiting
- Sponsor
- Shaanxi Micot Technology Co., Ltd.
- Start
- Oct 2025
- Primary completion
- May 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MT200605 in ischemic stroke, sponsored by Shaanxi Micot Technology Co., Ltd.. Started Oct 2025; status: recruiting.
02
Drugs
MT200605
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07205328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07205328.